Pancreatic Cancer Treatment at CMN Hospital

If you’re searching for help with pancreatic cancer, we understand why you’re here. Pancreatic cancer can arrive unexpectedly, bringing pain, weight loss, digestive challenges, and fatigue. At CMN Hospital in San Luis Río Colorado, Mexico our four-week advanced alternative cancer treatment program is personalized for you by Dr. Edgar Payán after a careful review of your medical records, scans, labs, and current condition. His goal is simple: to offer you the most non-toxic most comprehensive protocol to strengthen your immune system, multiply your natural killer cells, increase oxygenation, support gentle detoxification, replenish nutrients, and bring real hope for your healing.

Your plan is individualized. His therapies are adjusted on how you’re responding, daily monitoring and by your your lab results.

Anti-Tumor Intravenous Therapy (IV Nutrients)

Many pancreatic cancer patients struggle to absorb nutrients by mouth. IV therapy delivers high-dose vitamin C, selenium, glutathione, B-complex, magnesium, and other vitamins and minerals directly into the bloodstream—bypassing digestion and easing stress on the pancreas. IV support is designed to restore energy, correct deficiencies, and provide antioxidant support for cellular health.

What the Science Says

Clinical and translational studies have explored high-dose IV vitamin C as an adjunct in pancreatic cancer, with signals of safety and potential benefit in symptoms and tolerance (PubMed overview). Curcumin and selenium are under investigation for anti-inflammatory and anti-tumor pathways in pancreatic models and early clinical work (curcumin; selenium).

Autologous Dendritic Cell Therapy

Dendritic cells are the “teachers” of your immune system. Using your own cells, they are prepared to better recognize pancreatic cancer–related antigens and then returned to your body to help “coach” T-cells into a more focused response. This is personalized immunotherapy aimed at awakening recognition where it’s been dulled.

What the Science Says

Dendritic cell vaccines have been studied in pancreatic cancer for safety and immune activation, with growing interest in combination strategies to enhance effect (DC vaccine studies; reviews).

Autologous Bone Marrow–Supported Immunotherapy (NK/T-Cell Support)

From a small bone marrow sample, CMN’s protocol focuses on supporting natural killer (NK) cells and T-cells—key defenders that can be depleted or suppressed. Cells are collected, prepared, and returned to your body to help restore immune balance and surveillance. Because they are your own cells, there is no graft rejection.

What the Science Says

NK cell function is often impaired in pancreatic ductal adenocarcinoma, and research is evaluating ways to bolster NK/T-cell activity in this disease (NK cells & PDAC; adoptive cell therapy in PDAC).

What Are Natural Killer (NK) Cells?

NK cells are part of your innate immunity—rapid responders that can recognize stressed or abnormal cells without prior “training.” In pancreatic cancer care, supporting NK cells can add a non-toxic, natural line of defense alongside T-cell–based responses.

Ozone Therapy (MAH, Rectal Ozone, Transdermal Ozone)

Medical ozone is a controlled form of oxygen used to support oxygen delivery, modulate oxidative stress, and encourage gentle detoxification. At CMN, ozone may be applied via major autohemotherapy (MAH—ozone mixed with a small amount of your blood and returned), rectal ozone (supporting the gut and elimination), and transdermal methods. The intent is to improve tissue oxygen dynamics, support immune balance, and ease the body’s handling of cellular “die-off.”

What the Science Says

Reviews describe ozone’s potential to influence redox pathways, oxygen utilization, and immune modulation; higher-quality clinical trials are still needed (ozone therapy reviews). Use at CMN is physician-guided and individualized.

Hyperbaric Oxygen Therapy (HBOT)

In a pressurized chamber, you breathe pure oxygen. This raises dissolved oxygen in blood and tissues—helping repair, reducing infection risk, and supporting energy. For pancreatic cancer, addressing tumor-related hypoxia is supportive for comfort and recovery.

What the Science Says

Preclinical pancreatic research explores HBOT’s role in reducing hypoxia and favorably shifting the tumor microenvironment; clinical safety in oncology settings is well documented (HBOT & pancreatic cancer; HBOT safety).

Ultraviolet Blood Irradiation (UBI)

UBI involves taking a small amount of blood, gently exposing it to specific wavelengths of ultraviolet light, and returning it to the body. It’s used to support immune balance and reduce microbial burden, with the aim of helping the body respond more clearly and calmly.

What the Science Says

Historical and modern reviews describe UBI’s immune-modulating potential and effects on inflammation; pancreatic-specific trials are emerging (UBI & immunity).

Far Infrared Therapy

Far infrared (FIR) uses gentle radiant heat to promote comfort, circulation, and relaxation. In an integrative plan, FIR is used to ease tension, support detox pathways (sweat/skin), and help with rest—important for anyone experiencing pancreatic cancer–related exhaustion or stress.

What the Science Says

Studies in supportive oncology and rehabilitation contexts discuss FIR’s roles in comfort, circulation, and quality-of-life measures; research continues on optimal protocols (FIR supportive care).

Gentle Detox & “Die-Off” Support

As your body clears damaged or dying cells, you may feel temporary fatigue or flu-like sensations. CMN’s team monitors labs, hydration, electrolytes, and comfort measures (including nutrition, FIR, ozone applications, and IV support) to help your body process waste gently and safely.

Why Chemotherapy Often Helps Less in Pancreatic Cancer — Especially When It Has Spread to the Liver

People ask this every day. The compassionate, scientific truth is that pancreatic ductal adenocarcinoma (PDAC) has unique biology and a tumor environment that make many drugs less effective, and those challenges grow when the cancer reaches the liver:

• Dense stromal “scar” blocks drug delivery. PDAC builds thick fibrotic tissue that compresses tiny vessels and raises internal pressure, limiting how much drug can actually reach tumor cells.
• Low blood flow and hypoxia. Pancreatic tumors are often under-perfused and oxygen-poor; hypoxia activates survival pathways that blunt drug effects.
• Common gene changes drive resistance. Frequent mutations (e.g., KRAS, with TP53, CDKN2A, SMAD4) rewire growth and repair signaling, promoting survival under treatment.
• Drug-efflux and stress-response programs. Many PDAC cells overexpress transporters (drug pumps) and up-regulate autophagy/DNA-repair—reducing intracellular drug levels and damage.
• Immune-suppressive microenvironment. Cancer-associated fibroblasts, myeloid-derived suppressors, and certain macrophages dampen anti-tumor immunity and support resistance.
• Tumor diversity and rapid evolution. Different pockets of cells respond differently; resistant clones can expand quickly.
• Why liver spread adds difficulty. The liver’s biology (sinusoidal flow, Kupffer/stellate cells, detox enzymes) creates a protective niche; drug handling can change, and dose reductions may be needed when the liver is stressed.
• Whole-body strain. Weight loss and fatigue can limit aggressive dosing; lower doses may mean less effect.

None of this means chemotherapy never helps—some people do benefit. It means pancreatic cancer often needs additional support: improving oxygenation and blood flow, easing pressure around tumors, nourishing the body, and encouraging immune recognition. That is the heart of CMN Hospital’s four-week, non-toxic program—personalized care designed to strengthen, not strip, the person in the bed.

Personalized Four-Week Program

Your plan is built for you. Dr. Edgar Payán customizes treatment after reviewing your history and current condition—adjusting therapies day-by-day to match your strength, symptoms, and goals. Many people come to CMN in San Luis Río Colorado, Mexico seeking a non-toxic path that supports the immune system, improves oxygenation, nourishes deeply, and offers hope.

• Daily physician oversight with compassionate nursing support
• Organic, non-GMO, plant-forward meals tailored to tolerance
• IV nutrient protocols personalized to labs
• Immune-focused therapies scheduled to your energy levels

Pancreatic Cancer: Frequently Asked Questions (FAQ)

Who is a good candidate for CMN’s four-week pancreatic cancer program?

People seeking an advanced holistic and non-toxic, physician-led approach that supports immunity, oxygenation, and nutrition—especially if eating is difficult, energy is low, or prior conventional treatments were not tolerated or an option.

How are therapies personalized for pancreatic cancer?

Dr. Payán reviews your records, scans, labs, and current condition, then customizes a plan combines IV nutrients, immune-focused therapies (dendritic cell, autologous marrow-supported NK/T-cell support), oxygen-based care (HBOT, ozone/MAH), and gentle detox supports (FIR, UBI, nutrition). Plans are adjusted daily to how you feel and what labs show.

Are these therapies less invasive?

Yes. Most therapies are delivered by IV, chamber sessions (HBOT), light-based blood treatment (UBI), or controlled ozone applications. They are designed to be gentle and restorative.

Can I come if I’ve already had chemotherapy or surgery?

Yes. Many patients arrive after previous treatments. Your plan will consider what you’ve already done and how your body is doing now.

Will this replace my doctor back home?

No. CMN’s program supports your health during the four-week stay. We encourage continued coordination with your local physicians.

Is there published research behind these therapies?

Yes—ranging from preclinical to clinical studies (see “What the Science Says” links above: IV vitamin C, curcumin, selenium; dendritic cell vaccines; NK/T-cell strategies; HBOT; ozone; UBI; FIR). These are used here to support the body’s own defenses.

What results should I expect?

Every person is unique. Many patients report better energy, appetite, and comfort, and a greater sense of strength. Your plan is designed to support your well-being and immune function; individual results vary.